메뉴 건너뛰기




Volumn 27, Issue 1, 2012, Pages 55-60

Plasma clomipramine levels in adult patients with obsessive-compulsive disorder

Author keywords

clomipramine; drug metabolism; high performance liquid chromatography; obsessive compulsive disorder; plasma levels; sex; Yale Brown Obsessive Compulsive Scale

Indexed keywords

CLOMIPRAMINE; NORCLOMIPRAMINE;

EID: 83055194305     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32834cde39     Document Type: Article
Times cited : (10)

References (50)
  • 1
    • 0036109031 scopus 로고    scopus 로고
    • Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder
    • DOI 10.1097/00004714-200206000-00012
    • Ackerman DL, Greenland S (2002). Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol 22: 309-317. (Pubitemid 34546847)
    • (2002) Journal of Clinical Psychopharmacology , vol.22 , Issue.3 , pp. 309-317
    • Ackerman, D.L.1    Greenland, S.2
  • 3
    • 0034177434 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability
    • DOI 10.1016/S0165-0327(99)00092-0, PII S0165032799000920
    • Anderson IM (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J Affect Disord 58:19-36. (Pubitemid 30173208)
    • (2000) Journal of Affective Disorders , vol.58 , Issue.1 , pp. 19-36
    • Anderson, I.M.1
  • 4
    • 55449134899 scopus 로고    scopus 로고
    • The medical treatment of obsessive-compulsive disorder and anxiety
    • Bandelow B (2008). The medical treatment of obsessive-compulsive disorder and anxiety. CNS Spectr 13:37-46.
    • (2008) CNS Spectr , vol.13 , pp. 37-46
    • Bandelow, B.1
  • 6
    • 0029852799 scopus 로고    scopus 로고
    • Minimum effective dose for antidepressants - An obligatory requirement for antidepressant drug evaluation?
    • Benkert O, Szegedi A, Wetzel H (1996). Minimum effective dose for antidepressants-an obligatory requirement for antidepressant drug evaluation? Int Clin Psychopharmacol 11:177-185. (Pubitemid 26361790)
    • (1996) International Clinical Psychopharmacology , vol.11 , Issue.3 , pp. 177-185
    • Benkert, O.1    Szegedi, A.2    Wetzel, H.3
  • 7
    • 0026786382 scopus 로고
    • Clomipramine plasma levels among depressed outpatients in Benin, West Africa: Drug compliance and comparison with Caucasian patients
    • Bertschy G, Vandel S (1992). Clomipramine plasma levels among depressed outpatients in Benin, West Africa: Drug compliance and comparison with Caucasian patients. J Clin Psychopharmacol 12:334-336.
    • (1992) J Clin Psychopharmacol , vol.12 , pp. 334-336
    • Bertschy, G.1    Vandel, S.2
  • 8
    • 0033817411 scopus 로고    scopus 로고
    • Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, parox-etine or venlafaxine
    • Charlier C, Pinto E, Ansseau M, Plomteux G (2000). Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine,clomipramine, parox-etine or venlafaxine. Hum Psychopharmacol 15:453-459.
    • (2000) Hum Psychopharmacol , vol.15 , pp. 453-459
    • Charlier, C.1    Pinto, E.2    Ansseau, M.3    Plomteux, G.4
  • 9
    • 0022063137 scopus 로고
    • Plasma levels of clomipramine and its metabolites in hospitalized depressed patients
    • Debray Q, Goyot C, Plaisant O, Pelicier Y, Grenier J (1985). Plasma levels of clomipramine and its metabolites in hospitalized depressed patients. Ann Med Psychology 143:464-474.
    • (1985) Ann Med Psychology , vol.143 , pp. 464-474
    • Debray, Q.1    Goyot, C.2    Plaisant, O.3    Pelicier, Y.4    Grenier, J.5
  • 10
    • 0020521590 scopus 로고
    • Double-blind trial with oral versus intravenous clomipramine in primary depression
    • Faravelli C, Broadhurst AD, Ambonetti A, Ballerini A, De Biase L, La Malfa G, et al. (1983). Double-blind trial with oral versus intravenous clomipramine in primary depression. Biol Psychiatry 18:695-706. (Pubitemid 13067603)
    • (1983) Biological Psychiatry , vol.18 , Issue.6 , pp. 695-706
    • Faravelli, C.1    Broadhurst, A.D.2    Ambonetti, A.3
  • 11
    • 0021368437 scopus 로고
    • Plasma levels and clinical response during treatment with clomipramine
    • DOI 10.1016/0165-0327(84)90011-9
    • Faravelli C, Ballerini A, Ambonetti A, Broadhurst AD, Das M (1984). Plasma levels and clinical response during treatment with clomipramine. J Affect Disord 6:95-107. (Pubitemid 14158976)
    • (1984) Journal of Affective Disorders , vol.6 , Issue.1 , pp. 95-107
    • Faravelli, C.1    Ballerini, A.2    Ambonetti, A.3
  • 12
    • 15244351436 scopus 로고    scopus 로고
    • Evidence-based pharmacotherapy of obsessive-compulsive disorder
    • DOI 10.1017/S1461145704004675
    • Fineberg NA, Gale TM (2005). Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol 8:107-129. (Pubitemid 40388819)
    • (2005) International Journal of Neuropsychopharmacology , vol.8 , Issue.1 , pp. 107-129
    • Fineberg, N.A.1    Gale, T.M.2
  • 14
    • 0021972864 scopus 로고
    • Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study
    • Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, et al. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study. Arch Gen Psychiatry 42:977-983. (Pubitemid 15245091)
    • (1985) Archives of General Psychiatry , vol.42 , Issue.10 , pp. 977-983
    • Flament, M.F.1    Rapoport, J.L.2    Berg, C.J.3
  • 18
    • 41049118341 scopus 로고    scopus 로고
    • Therapeutic drug monitoring in neuropsychopharmacology: Does it hold its promises?
    • DOI 10.1007/s00406-007-1005-y
    • Hiemke C (2008). Therapeutic drug monitoring in neuropsychopharma-cology: Does it hold its promises? Eur Arch Psychiatry Clin Neurosci 258: 21-27. (Pubitemid 351421448)
    • (2008) European Archives of Psychiatry and Clinical Neuroscience , vol.258 , Issue.SUPPL. 1 , pp. 21-27
    • Hiemke, C.1
  • 19
    • 0020582680 scopus 로고
    • Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline
    • Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M (1983). Obsessive-compulsive disorder: A double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 40:605-612. (Pubitemid 13094927)
    • (1983) Archives of General Psychiatry , vol.40 , Issue.6 , pp. 605-612
    • Insel, T.R.1    Murphy, D.L.2    Cohen, R.M.3
  • 21
    • 0023898079 scopus 로고
    • Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: Relations between dose, plasma levels, outcome and side effects
    • Kasvikis Y, Marks IM (1988). Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: Relations between dose, plasma levels, outcome and side effects. Psychopharmacology 95:113-118.
    • (1988) Psychopharmacology , vol.95 , pp. 113-118
    • Kasvikis, Y.1    Marks, I.M.2
  • 23
    • 0019168588 scopus 로고
    • Clomipramine and doxepin in depressive neurosis. Plasma levels and therapeutic response
    • Linnoila M, Seppala T, Mattila MJ, Vihko R, Pakarinen A, Skinner T III (1980). Clomipramine and doxepin in depressive neurosis: Plasma levels and therapeutic response. Arch Gen Psychiatry 37:1295-1299. (Pubitemid 11241585)
    • (1980) Archives of General Psychiatry , vol.37 , Issue.11 , pp. 1295-1299
    • Linnoila, M.1    Seppala, T.2    Mattila, M.J.3
  • 24
    • 76449087603 scopus 로고    scopus 로고
    • Treatment strategies for obsessive-compulsive disorder
    • Marazziti D, Consoli G (2010). Treatment strategies for obsessive-compulsive disorder. Expert Opin Pharmacother 11:331-343.
    • (2010) Expert Opin Pharmacother , vol.11 , pp. 331-343
    • Marazziti, D.1    Consoli, G.2
  • 25
    • 77957969756 scopus 로고    scopus 로고
    • Past, present and future drugs for the treatment of obsessive-compulsive disorder
    • Marazziti D, Consoli G, Baroni S, Catena Dell'Osso M (2010). Past, present and future drugs for the treatment of obsessive-compulsive disorder. Curr Med Chem 17:3410-3421.
    • (2010) Curr Med Chem , vol.17 , pp. 3410-3421
    • Marazziti, D.1    Consoli, G.2    Baroni, S.3    Catena Dell'Osso, M.4
  • 26
    • 0033035883 scopus 로고    scopus 로고
    • Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder
    • Marcourakis T, Gorenstein C, Ramos RT, da Motta Singer J (1999). Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder. J Psychopharmacol 13:40-44. (Pubitemid 29141274)
    • (1999) Journal of Psychopharmacology , vol.13 , Issue.1 , pp. 40-44
    • Marcourakis, T.1    Gorenstein, C.2    Ramos, R.T.3    Da Motta Singer, J.4
  • 27
    • 0024996123 scopus 로고
    • The relationship of plasma clomipramine and n-desmethylclomipramine to response in obsessive-compulsive disorder
    • Mavissakalian M, Jones B, Olson S, Perel JM (1990a). The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder. Psychopharmacol Bull 26:119-122. (Pubitemid 20322257)
    • (1990) Psychopharmacology Bulletin , vol.26 , Issue.1 , pp. 119-122
    • Mavissakalian, M.1    Jones, B.2    Olson, S.3    Perel, J.M.4
  • 29
    • 0034918693 scopus 로고    scopus 로고
    • S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine
    • Millan MJ, Gobert A, Lejune F, Newman-Tancredi A, Rivet JM, Auclair A, et al. (2001). S33005, a novel ligand at both serotonin and norepinephrine transporters: I: Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipra-mine. J Pharmacol Exp Ther 298:565-580. (Pubitemid 32673407)
    • (2001) Journal of Pharmacology and Experimental Therapeutics , vol.298 , Issue.2 , pp. 565-580
    • Millan, M.J.1    Gobert, A.2    Lejeune, F.3    Newman-Tancredi, A.4    Rivet, J.-M.5    Auclair, A.6    Peglion, J.-L.7
  • 30
    • 0027481384 scopus 로고
    • Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs
    • Monsma FJ (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:327.
    • (1993) Mol Pharmacol , vol.43 , pp. 327
    • Monsma, F.J.1
  • 31
    • 0018818487 scopus 로고
    • Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients
    • Montgomery SA, McAuley R, Montgomery DB, Dawling S, Braithwaite RA (1980). Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients. Postgrad Med J 56:130-133. (Pubitemid 10119402)
    • (1980) Postgraduate Medical Journal , vol.56 , Issue.SUPPL. 1 , pp. 130-133
    • Montgomery, S.A.1    McAuley, R.2    Montgomery, D.B.3
  • 32
    • 0027131435 scopus 로고
    • Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: Prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data
    • DOI 10.1016/0165-0327(93)90017-E
    • Noguchi T, Shimoda K, Takahashi S (1993). Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: Prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data. J Affect Disord 29:267-279. (Pubitemid 24003833)
    • (1993) Journal of Affective Disorders , vol.29 , Issue.4 , pp. 267-279
    • Noguchi, T.1    Shimoda, K.2    Takahashi, S.3
  • 34
    • 0023241871 scopus 로고
    • CLOMIPRAMINE ET DEMETHYLCLOMIPRAMINE. CORRELATION TAUX PLASMATIQUES/EFFICACITE CHEZ 24 DEPRIMES
    • Pascalis G, Wargny E, Lamiable D, Havet JM (1987). Clomipramine and demethylclomipramine: Correlation of plasma levels and efficacy in 24 depressive patients. Encephale 13:239-244. (Pubitemid 17141235)
    • (1987) Encephale , vol.13 , Issue.4 , pp. 239-244
    • Pascalis, G.1    Wargny, E.2    Lamiable, D.3    Havet, J.M.4
  • 35
    • 0028093608 scopus 로고
    • Tricyclic antidepressant concentrations in plasma: An estimate of their sensitivity and specificity as a predictor of response
    • Perry PJ, Zeilmann C, Arndt S (1994). Tricyclic antidepressant concentrations in plasma: An estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol 14:230-240. (Pubitemid 24254714)
    • (1994) Journal of Clinical Psychopharmacology , vol.14 , Issue.4 , pp. 230-240
    • Perry, P.J.1    Zeilmann, C.2    Arndt, S.3
  • 36
    • 0037024144 scopus 로고    scopus 로고
    • Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction
    • DOI 10.1016/S1570-0232(02)00089-2, PII S1570023202000892
    • Pirola R, Mundo E, Bellodi L, Bareggi SR (2002). Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci 5:205-210. (Pubitemid 34499566)
    • (2002) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences , vol.772 , Issue.2 , pp. 205-210
    • Pirola, R.1    Mundo, E.2    Bellodi, L.3    Bareggi, S.R.4
  • 37
    • 0024342790 scopus 로고
    • Tricyclic antidepressants: The whys and hows of therapeutic drug monitoring
    • Preskorn SH (1989). Tricyclic antidepressants: The whys and hows of therapeutic drug monitoring. J Clin Psychiatry 50:34-46.
    • (1989) J Clin Psychiatry , vol.50 , pp. 34-46
    • Preskorn, S.H.1
  • 38
    • 0025779099 scopus 로고
    • Therapeutic drug monitoring for antidepressants: Efficacy, safety, and cost effectiveness
    • Preskorn SH, Fast GA (1991). Therapeutic drug monitoring for antidepressants: Efficacy, safety, and cost effectiveness. J Clin Psychiatry 52:23-33.
    • (1991) J Clin Psychiatry , vol.52 , pp. 23-33
    • Preskorn, S.H.1    Fast, G.A.2
  • 39
    • 37349026204 scopus 로고    scopus 로고
    • High-dose escitalopram for the treatment of obsessive-compulsive disorder
    • DOI 10.1097/YIC.0b013e3282f0f0c5, PII 0000485020080100000007
    • Rabinowitz I, Baruch Y, Barak Y (2008). High-dose escitalopram for the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 23:49-53. (Pubitemid 350294870)
    • (2008) International Clinical Psychopharmacology , vol.23 , Issue.1 , pp. 49-53
    • Rabinowitz, I.1    Baruch, Y.2    Barak, Y.3
  • 40
    • 0018412441 scopus 로고
    • Plasma levels of tricyclic antidepressants and clinical efficacy: Review of the literature. Part II
    • Risch SC, Huey LY, Janowsky DS (1979). Plasma levels of tricyclic antidepres-sants and clinical efficacy: Review of the literature-part II. J Clin Psychiatry 40:58-69. (Pubitemid 9107119)
    • (1979) Journal of Clinical Psychiatry , vol.40 , Issue.2 , pp. 58-69
    • Risch, S.C.1    Huey, L.Y.2    Janowsky, D.S.3
  • 42
    • 0028905968 scopus 로고
    • Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder
    • Stein DJ, Spadaccini E, Hollander E (1995). Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 10:11-18.
    • (1995) Int Clin Psychopharmacol , vol.10 , pp. 11-18
    • Stein, D.J.1    Spadaccini, E.2    Hollander, E.3
  • 43
    • 80051680684 scopus 로고    scopus 로고
    • Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry
    • Stephan PL, Etzensberger M, Jaquenoud Sirot E (2006). Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry. Praxis (Bern 1994) 26:671-678.
    • (2006) Praxis (Bern 1994) , vol.26 , pp. 671-678
    • Stephan, P.L.1    Etzensberger, M.2    Jaquenoud Sirot, E.3
  • 44
    • 0017652982 scopus 로고
    • A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis
    • Stern RS, Cobb JP, Marks IM, Jones RB, Luscombe DK (1977). A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis. Postgrad Med J 53:97-103. (Pubitemid 8234907)
    • (1977) Postgraduate Medical Journal , vol.53 , Issue.SUPPL. 4 , pp. 97-103
    • Stern, R.S.1    Cobb, J.P.2    Marks, I.M.3
  • 45
    • 0018861599 scopus 로고
    • Clomipramine and exposure for compulsive rituals: II. Plasma levels, side effects and outcome
    • Stern RS, Marks IM, Mawson D, Luscombe DK (1980). Clomipramine and exposure for compulsive rituals: II. Plasma levels, side effects and outcome. Br J Psychiatry 136:161-166. (Pubitemid 10183251)
    • (1980) British Journal of Psychiatry , vol.136 , Issue.2 , pp. 161-166
    • Stern, R.S.1    Marks, I.M.2    Mawson, D.3    Luscombe, D.K.4
  • 46
    • 79959922915 scopus 로고    scopus 로고
    • NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primate in vivo
    • Takano A, Nag S, Gulyas B, Halldin C, Farde L (2011). NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primate in vivo. Psychopharmacol 216:279-286.
    • (2011) Psychopharmacol , vol.216 , pp. 279-286
    • Takano, A.1    Nag, S.2    Gulyas, B.3    Halldin, C.4    Farde, L.5
  • 48
    • 0025572195 scopus 로고
    • Tricyclic antidepressant plasma level monitoring: Intraindividual variability in everyday practice
    • Vandel S, Bertschy G, Nezeloff S, Bonin B, Volmat R (1990). Tricyclic antidepressant plasma level monitoring: Intraindividual variability in everyday practice. Eur J Clin Pharmacol 39:611-612.
    • (1990) Eur J Clin Pharmacol , vol.39 , pp. 611-612
    • Vandel, S.1    Bertschy, G.2    Nezeloff, S.3    Bonin, B.4    Volmat, R.5
  • 49
    • 0026326022 scopus 로고
    • Use of plasma level monitoring of antidepressants in clinical practice: Towards an analysis of clinical utility
    • Vuille F, Amey M, Baumann P (1991). Use of plasma level monitoring of antidepressants in clinical practice: Towards an analysis of clinical utility. Pharmacopsychiatry 24:190-195.
    • (1991) Pharmacopsychiatry , vol.24 , pp. 190-195
    • Vuille, F.1    Amey, M.2    Baumann, P.3
  • 50
    • 0023019568 scopus 로고
    • Plasma levels of clomipramine and declomipramine in patients with depression: A study of its correlation with therapeutic efficacy
    • Wargny E, Lamiable D, Havet JM, Denis J, Millart H, Choisy H, et al. (1986). Plasma levels of clomipramine and declomipramine in patients with depression: A study of its correlation with therapeutic efficacy. Ann Med Psychol 144:396-406.
    • (1986) Ann Med Psychol , vol.144 , pp. 396-406
    • Wargny, E.1    Lamiable, D.2    Havet, J.M.3    Denis, J.4    Millart, H.5    Choisy, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.